Overview: CCSA Fact Sheets for Substance Use Health
The CCSA has developed a series of evidence-informed resources to help individuals, healthcare providers, and policy makers understand complex responses to the toxic drug crisis. These resources bridge the gap between scientific research and community-level action, focusing on reducing stigma and saving lives.
Key Topics & Evidence
1. Supervised Consumption Sites (SCS)
- The Critical Need: Between January 2016 and March 2024, more than 47,000 people in Canada died due to the unregulated drug supply.
- How They Help: SCSs provide a safe, supportive environment that connects individuals to healthcare and social services. They are evidence-based interventions that significantly reduce the risk of fatal overdose.
2. Drug Checking Services
- Empowering Decisions: These services help people identify what is actually in their drugs, which is vital given the unpredictability and toxic nature of the unregulated supply.
- Community Benefit: Beyond individual safety, drug checking provides real-time data to communities about what substances are circulating, allowing for faster public health responses.
3. Opioid Agonist Therapy (O.A.T.)
- A Personalized Path: O.A.T. uses medication to help individuals achieve their specific health goals—whether that is reducing use or stopping opioids entirely.
- Stabilization: It helps manage withdrawal symptoms and cravings, allowing individuals to stabilize their lives and engage in other forms of support.
4. Emerging Research: GLP-1s & Substance Use
- New Horizons: The CCSA is exploring the use of GLP-1 receptor agonists (medications often used for diabetes or weight loss) as a potential tool to support people living with substance use disorders.
- The Barrier: While research is developing, there are still significant systemic and policy barriers to implementing these treatments widely.
5. Involuntary Treatment
- The Debate: The fact sheets explore the complex intersection of public safety, human rights, and healthcare effectiveness regarding involuntary treatment for severe substance use disorders.
- The Evidence: The materials provide a balanced look at the legislation and the diverse perspectives from those with lived and living experience.